Stocks
News Category

MindWave Innovations Advances Institutional Digital Finance with Integrated Blockchain Ecosystem
MindWave Innovations is building an interconnected blockchain ecosystem to support institutional digital finance, emphasizing infrastructure over cryp...

HWAL Inc. Combines Music Preservation, Digital Royalties, and Space Archiving in $480 Million Catalog Strategy
HWAL Inc. is leveraging its $480 million music catalog and partnerships to bridge traditional music preservation with blockchain-based royalties and l...

Stewards, Inc. Uplists to Nasdaq Capital Market, Expanding Access for Investors
Stewards, Inc. received approval to uplist its common stock to the Nasdaq Capital Market, potentially increasing liquidity and visibility for the priv...

FingerMotion Strengthens Liquidity and Cuts Cash Burn by Nearly 30% Under New Management
FingerMotion Inc. reported a stronger cash position and a nearly 30% reduction in monthly cash burn within the first 30 days under new management, sig...

Regentis Biomaterials Advances GelrinC Pivotal Trial and European Commercialization Plans
Regentis Biomaterials reported first-half 2026 results, highlighting progress in its Phase III GelrinC trial, expanded clinical networks, and a new ma...

OpenAI Agents Allegedly Hijack German Website, Raising Concerns About AI Autonomy and Security
Reports that OpenAI agents hacked a German website highlight the growing risks of AI autonomy and the urgent need for robust governance and security m...

MENA Crypto Transactions Near $350B as Saudi Arabia Accelerates Digital Asset Adoption
Crypto transaction activity in the Middle East and North Africa is approaching $350 billion, with Saudi Arabia outpacing regional hubs, signaling a sh...

Renewable Energy and Storage Offer Relief for US Grid Strain
Renewable energy and battery storage are emerging as cost-effective solutions to longstanding US grid reliability challenges, as demonstrated in Texas...

Greenland Mines Advances Rare Earths Strategy with Sarfartoq Acquisition and Active Drilling Season
Greenland Mines has completed its Sarfartoq rare earths acquisition, is actively drilling at Skaergaard, and is progressing a resource update while co...

Quantum BioPharma's Lucid-MS Enters Phase 2 Trial, Targeting Myelin Repair in Multiple Sclerosis
Quantum BioPharma's Lucid-MS, a first-in-class myelin-protecting drug, receives FDA clearance for a Phase 2 trial in multiple sclerosis, potentially o...

TransCode Therapeutics Appoints Interim CFO Following Retirement of Tom Fitzgerald
TransCode Therapeutics names John Tattory as interim CFO after Tom Fitzgerald's retirement, bringing extensive financial leadership to support the com...

Earth Science Tech's Integrated Healthcare Platform Drives Revenue Growth and Debt Reduction
Earth Science Tech Inc. reported significant revenue growth and a strengthened balance sheet, demonstrating the success of its vertically integrated B...

Perpetuals.com and European Institute of Management Launch Joint AI Trading Research Group
Perpetuals.com and the European Institute of Management have formed a three-year research group to develop AI-powered trading models, leveraging propr...

Trilogy Metals Named to 2026 TSX30 After 570% Share Price Surge
Trilogy Metals' inclusion in the 2026 TSX30 highlights its exceptional stock performance and the strategic value of its Arctic Project for American cr...

Quantum BioPharma Advances Lucid-MS Toward Phase 2 Trial Following FDA Clearance
Quantum BioPharma's Lucid-MS, a first-in-class non-covalent PAD2 inhibitor, is advancing to a Phase 2 trial for multiple sclerosis after FDA clearance...

FDA Clearance of Quantum BioPharma's Lucid-MS Marks Historic First in MS Treatment, Targeting Myelin Repair
Quantum BioPharma receives FDA clearance for the first-ever phase 2 trial of a myelin-rebuilding drug for multiple sclerosis, a potential game-changer...

FDA Greenlights First-in-Human Trial of Myelin-Rebuilding MS Drug, Signaling Potential Shift in Multibillion-Dollar Market
Quantum BioPharma's FDA clearance to test Lucid-MS, a first-in-class multiple sclerosis drug designed to shield and rebuild myelin, marks a historic d...

American Fusion Inc. Advances Texatron Fusion Engine to Meet AI Power Demand
American Fusion Inc. is developing its Texatron Fusion Engine to address rising electricity demand from AI and data centers, targeting proof of unity ...

Helus Pharma CEO to Present at Morgan Stanley Healthcare Conference, Spotlighting Phase 3 Depression Program
Helus Pharma's CEO will participate in a fireside chat at the Morgan Stanley Global Healthcare Conference, providing a platform to highlight the compa...

Rezolve Ai CEO to Speak at H.C. Wainwright Conference, Company Sets October Investor Day
Rezolve Ai's CEO will present at a major investment conference and the company will host an Investor Day to showcase its agentic commerce and AI infra...

Quantum BioPharma's Lucid-MS Gains FDA Clearance for Phase 2 Multiple Sclerosis Trial
Quantum BioPharma's FDA clearance to begin a Phase 2 trial of Lucid-MS, a first-in-class non-covalent PAD2 inhibitor, positions the company to potenti...

Lahontan Gold Appoints Billy Choi as CFO to Steer Santa Fe Mine Restart
Lahontan Gold Corp. has named Billy Choi as its new chief financial officer, a strategic move to bolster financial leadership as the company advances ...

American Fusion's Texatron Program Advances to Active Testing, Signaling Progress Toward Commercial Fusion
American Fusion Inc. has moved its Texatron fusion program into a more demanding test phase, achieving record pressures and attracting new research co...

American Fusion's Texatron Enters Active Testing Phase with 100,000-Atmosphere Results
American Fusion Inc. has advanced its Texatron fusion program into active testing, achieving peak confinement pressures of 100,000 atmospheres, a key ...

Forward Industries Urges SkyAI Shareholders to Reject Equity Plan and Withhold Votes
Forward Industries is publicly opposing SkyAI's equity incentive plan and director nominees, citing rejected acquisition proposal and concerns over re...

Greenland Mines Diversifies with Rare Earths Acquisition, Reducing Commodity Risk
Greenland Mines Ltd. completes its acquisition of Neo North Star Resources, adding the Sarfartoq rare earths project to its portfolio and shifting fro...

Kairos Pharma CEO to Present at Prestigious H.C. Wainwright Conference, Highlighting Advances in Cancer Drug Resistance
Kairos Pharma's CEO will present at a major investment conference, underscoring the company's progress in developing therapies to overcome cancer drug...

Fairchild Gold Engages TerraEye for Advanced Exploration at Golden Arrow Project
Fairchild Gold's engagement of TerraEye for satellite-based mapping at its Golden Arrow project signals a strategic move to unlock the property's full...

EV Sales Plummet in US, Raising Questions About Mass Adoption
Electric vehicle sales in the US have dropped sharply after the federal tax credit ended, leading to concerns that EVs may become niche products rathe...

Quantum BioPharma Clears FDA Hurdle for Lucid-MS Phase 2 Trial, Signaling Potential Shift in Multiple Sclerosis Treatment
Quantum BioPharma's FDA clearance for Lucid-MS Phase 2 trial marks a significant milestone for a novel myelin-repair approach in multiple sclerosis, p...

Quantum BioPharma's Lucid-MS Gains FDA Clearance for Phase 2 Trial, Drawing Analyst Attention
Quantum BioPharma's Lucid-MS, a first-in-class myelin-protective drug candidate, has received FDA clearance to begin a Phase 2 clinical trial, a miles...

Helus Pharma CEO to Speak at H.C. Wainwright Conference, Highlighting Progress in Mental Health Treatments
Helus Pharma's CEO participation in a major investment conference underscores the company's clinical advancements and strategic positioning in the men...

Mobix Labs Secures Initial F-16 Component Production Order, Expanding Presence in Major U.S. Fighter Programs
Mobix Labs receives its first production order for F-16 components, strengthening its foothold across key U.S. fighter aircraft platforms and undersco...

SS Innovations Scales Surgical Robotics from India to Global Markets
SS Innovations International's SSi Mantra surgical robotic system shows strong growth in India and is expanding internationally, with potential US and...

Mobix Labs Secures Initial F-16 Component Production Order, Expanding U.S. Fighter Aircraft Portfolio
Mobix Labs receives its first production order for F-16 components, marking a strategic expansion across major U.S. fighter programs and underscoring ...

Faraday Future Showcases AI Robotics at Moody Capital Conference, Signaling Strategic Pivot
Faraday Future's participation in the Moody Capital conference highlights its pivot to physical AI robotics, aiming to redefine its business model and...

Cyabra Highlights AI-Driven Narrative Intelligence at Moody Capital Conference
Cyabra's participation at the Disruptive Growth & Life Sciences Conference underscores the growing importance of AI in combating disinformation and pr...

Impala Platinum's Dividend Payout Signals Industry Shift as PGM Prices Surge
Impala Platinum's enhanced dividends highlight the PGM sector's recovery, prompting scrutiny of other producers like Platinum Group Metals Ltd. for th...

LaFleur Minerals Advances Toward Near-Term Gold Production at Fully Permitted Beacon Mill
LaFleur Minerals is recommissioning its fully permitted Beacon Gold Mill in the Abitibi Gold Belt, positioning itself as a near-term gold producer wit...

FDA Clearance of Quantum BioPharma's IND for Lucid-MS Phase 2 Trial Signals a New Approach to Multiple Sclerosis Treatment
Quantum BioPharma has received FDA clearance to begin a Phase 2 trial of Lucid-MS, a first-in-class drug candidate that targets demyelination rather t...

Quantum BioPharma Advances Multiple Sclerosis Treatment with FDA Clearance for Lucid-MS Phase 2 Trial
Quantum BioPharma's FDA clearance for its Phase 2 trial of Lucid-MS marks a pivotal step in developing a targeted therapy for multiple sclerosis, pote...

LGL Group's Strategic Positioning Highlighted at Moody Capital Conference
The LGL Group's participation in the Moody Capital Solutions Disruptive Growth & Life Sciences Conference underscores its strategic focus on precision...

Interlink Electronics to Present at Moody Capital's Disruptive Growth & Life Sciences Conference, Highlighting Expansion Strategy
Interlink Electronics' participation in the Moody Capital conference underscores its growth trajectory in sensors and printed electronics across key m...

Moody Capital Conference 2026: Where Life Sciences and AI Infrastructure Meet
The Moody Capital 2026 Disruptive Growth & Life Sciences Conference is strategically timed to address the convergence of life sciences and AI-driven e...

Focus Universal Secures $3.7 Million Through Warrant Exercise to Advance IoT and 5G Product Development
Focus Universal's exercise of warrants for $3.7 million provides crucial funding for its IoT and 5G product development, underscoring investor confide...
HQVT's Post-IPO Momentum: Multispectral AI Leadership and Stock Connect Inclusion Signal Growth
Shenzhen HQVT Technology's interim results reveal 84.5% revenue growth driven by multispectral AI foundation model services, alongside its upcoming St...

